Pharmasset Ltd., Roche deal

ROCZ licensed from Pharmasset worldwide rights to PSI-6130, a nucleoside polymerase inhibitor, and its prodrugs to

Read the full 167 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE